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Abstract
Mutations in the GJB2 gene are a main cause of autosomal-recessive nonsyndromic
hearing loss (ARNSHL) in many populations. Previous studies have estimated the
average frequency of GJB2 mutations to be ∼16% in Iran, but would vary among
different ethnic groups. Here, we have taken together and reviewed results from our
two previous publications and data from searching other published mutation reports
to provide a comprehensive collection of data for GJB2 mutations and HL in central
Iran. In all, 332 unrelated families were included and analyzed for the prevalence and
type of theGJB2 gene mutations. In total, the frequency ofGJB2mutations was found
to be 16% in the central provinces, which is significantly higher than those identified
in southern populations of Iran. Also, c.35delG was the most frequent mutation in
the related population. The present study suggests that mutations in the GJB2 gene,
especially c.35delG, are important causes of HL in central Iran and can be used as a
basis of genetic counseling and clinical guidelines in this region.
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1 INTRODUCTION
Hearing loss (HL) is a complex impairment and accounts
for one to two of 1,000 newborns all over the world
(http://hearing.screening.nhs.uk/nationalprog). Many envi-
ronmental agents, such as drug exposure, bacterial or viral
infections, and trauma, can cause HL; however, a signif-
icant proportion of cases is related to genetic factors. It
is estimated that 70% of cases includes nonsyndromic HL
(NSHL), where HL is not associated with additional clinical
features (Morton, 1991). Although all Mendelian inheritance
patterns have been observed for prelingual HL, autosomal-
recessive modes of inheritance (ARNSHL) makes up 80%
of the NSHL cases (Morton & Nance, 2006). ARNSHL is
highly heterogeneous, for which over 100 mapped loci are
known to be involved (http://hereditaryhearingloss.org). Nev-
ertheless, a single locus, DFNB1(13q11-12) which contains
GJB2 (NM_004004.5) and GJB6 (NM_001110219.2) genes,
accounts for about 50% of the etiology in many Western pop-
ulations (Gasparini et al., 2000; Van Laer et al., 2001). GJB2
encodes the connexin 26 protein (Cx26), which is a type of
gap junction protein involved in the inner ear homeostasis
of the cochlear fluids, endolymph and perilymph, through
recycling of potassium ions (Maeda et al., 2009). The gene
has a simple genomic structure consisting of 680 bp can be
sequenced simply (Zelante et al., 1997). To date, more than
100 pathogenic mutations in the GJB2 gene have been iden-
tified resulting in ARNSHL (http://davinci.crg.es/deafness).
The prevalence of GJB2 mutations varies among differ-
ent populations (Azadegan-Dehkordi, Ahmadi, Koohiyan, &
Hashemzadeh-Chaleshtori, 2019b; Talbi et al., 2019). In Cau-
casians, c.35delG is the most common mutation with the
carrier frequency as high as 2%–4% (Pandya et al., 2003;
Seeman et al., 2005). However, c.235delC and p.Trp24* are
the most frequent mutations in the Japanese (Abe, Usami,
Shinkawa, Kelley, & Kimberling, 2000; Nishio & Usami,
2015) and Indians (Bhalla, Sharma, Khandelwal, Panda, &
Khullar, 2009; RamShankar et al., 2003), respectively. Iran’s
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population is ∼80 million, with HL affecting an estimated
more than 450,000 individuals. In other words, one in 166
individuals is affected, which makes it a major public health
issue (Mahdieh, Bagherian, Shirkavand, Sharafi, & Zeinali,
2010).
Over the last decade, a series of studies have been con-
ducted on the Iranian population to identify the mutation
spectrum and prevalence of GJB2 mutations (Azadegan-
Dehkordi et al., 2019a; Falah et al., 2019; Hashemzadeh-
Chaleshtori et al., 2008; Hosseinipour et al., 2005; Koohiyan
& Ahmadi, 2019; Mahdieh, Mahmoudi, Ahmadzadeh, &
Bakhtiyari, 2016; Sadeghi et al., 2009). The diverse ethnici-
ties, coupled with the high rate of consanguinity rates (38% in
average) (Saadat, 2005), tend to change mutation frequencies
among ethnic groups (Mahdieh et al., 2011; Sloan-Heggen
et al., 2015). Therefore, for accurate and effective genetic
counseling, studying certain ethnic groups is of high impor-
tance (Babanejad et al., 2012; Bakhchane et al., 2016). In this
paper, we summarized the published data on the frequency
and profile of the GJB2 gene mutations in 332 unrelated fam-
ilies from six different provinces, namely, Lorestan, Isfahan,
Chaharmahal and Bakhtiari, Markazi, Qom, and Yazd, in the
central part of Iran.
2 METHODS
This study includes results from our two previous publications
on GJB2-related HL in Iran. We also performed a PubMed,
InterScience, and ScienceDirect search using search terms
“GJB2 mutations” or “connexin 26,” and “Iran.” Among the
search results, we limited the search to humanswho held infor-
mation on molecular genetics of HL. Studies were included
when fulfilling the following three criteria: (1) performance
on NSHL subjects, (2) described the ethnicity of tested sub-
jects, and (3) detection by comparable molecular methods.
Studies were excluded if HL was a result of environmental
factors such as infection, trauma, rubella, meningitis, mumps,
ototoxic drugs, and premature birth. Research data including
332 unrelated deaf families from the southern provinces were
collected. The frequency and mutation type of 332 deaf fami-
lies were extracted from relevant studies and categorized, cor-
responding with geographical boundaries. In silico analyses
were also performed by available software tools to predict the
pathogenicity of the mutation.
3 RESULTS
Data from 332 unrelated families were gathered for analy-
sis (Figure 1). The groups studied consisted of 120 families
from Yazd Province (36%), 79 families from Chaharmahal
F IGURE 1 Schematic structure, domains and distribution of
mutations of the Cx-26 protein in this study. The most common
mutations in central Iran (c.35delG, c.312del14, c.457G > A,
c.363delC, and c.358_360delGAG) are underlined [Colour figure can
be viewed at wileyonlinelibrary.com]
and Bakhtiari (24%), 54 families from Lorestan (16%), 40
families from Isfahan (12%), and 40 families from Qom and
Markazi (12%). The GJB2mutation frequencies of each stud-
ied group includes 31.2%, 18.8%, 16.25%, 7.5%, and 6.9% of
total studied families (n= 332) of Isfahan, Lorestan, Qom and
Markazi, Yazd, and Chaharmahal and Bakhtiari provinces,
respectively.
In total, 21 different variants were identified, 14 of which
were reported as pathogenic. These include c.35delG,
c.23_24insA, c.167delT, c.100A > G, c.163A > G,
c.79G > A, c.95G > A, c.233delC, c.35G > T, c.363delc,
c.510insCGAA, c.176del16, c.457G > A, c.130T > G,
-3170G > A, c.178T > G, c.358_360delGAG, c.312del14,
c.314del14, and c.512insAACG. In the studied populations,
c.35delG was the most frequent mutation. The highest rate
of c.35delG mutation was detected in Isfahan, accounting
for 15% of detected mutations, while this rate was 1.6%
in Yazd. Figure 2 shows the distribution of the identified
mutations in the schematic structure of Cx26. A specific
combination of GJB2 mutation types and frequencies were
found in different studied provinces (Table 1). A higher
number of GJB2 mutation diversity (12 types) was observed
in Isfahan province while the lowest diversity identified was
in Bakhtiari populations (four types).
4 DISCUSSION
This study reviews the prevalence and type of the GJB2 gene
mutations by means of a literature review and compares 332
deaf families from six provinces in central Iran. The genetic
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F IGURE 2 The prevalence of GJB2-related mutations in
different regions of Iran (northwest 22%–27%, north 27%–38%,
southeast 0%–4%). Six central provinces (Lorestan, Isfahan,
Chaharmahal and Bakhtiari, Markazi, Qom, and Yazd) are shown on
the map [Colour figure can be viewed at wileyonlinelibrary.com]
epidemiology of ARNSHL is very different among popula-
tions because of founder effects (Davarnia et al., 2012; Laleh
et al., 2017; Zarepour et al., 2019). The Iranian population
is composed of many different ethnic groups, so it is impor-
tant to discuss ethnic-specific data (Chaleshtori et al., 2002;
Haghighat-Nia et al., 2015; Koohiyan, 2019). Accepting the
northwest-to-southeast GJB2 HL gradient throughout Iran,
our data indicates a west-to-east gradient among Iranian popu-
lations with aGJB2mutations frequency of 31.2% for Isfahan
province and 7.5% for Yazd province. The results obtained
from other studies have shown that the mutation frequency
of GJB2 varies between 0% and 35% within different parts
of Iran (Bazazzadegan et al., 2012). The study performed
by Najmabadi et al. (Najmabadi et al., 2005) on 664 ARN-
SHL families indicated that GJB2-related HL accounts for
16.7% in the Iranian population and the c.35delG mutation
was the most common GJB2 mutation (∼72% of the iden-
tified GJB2 mutations). In another cohort study, Chalesh-
tori et al. (Chaleshtori, Farhud, & Patton, 2007) showed the
frequency of GJB2 mutations to be 27.5% in the north and
northwest provinces of Iran, while it was less than 4% in the
southeast region. The observed northwest-to-southeast GJB2
HL gradient is further supported by data specific to south-
east and northwest Iran, where the populations are related to
neighboring Oman and Turkey (Simsek et al., 2001; Yilmaz
et al., 2010). Bonyadi et al. (Bonyadi, Esmaeili, Abhari, &
Lotfi, 2009) showed that GJB2 mutations were responsible
for about 28% of ARNSHL in Iranian Azeri Turkish patients
(northwest Iran) and c.35delG was the most prevalent muta-
tion accounting for 64.5% of GJB2 mutations, which is simi-
lar to the reported results in the Turkish population (Duman,
Sirmaci, Cengiz, Ozdag, & Tekin, 2011; Kalay, Caylan, Kre-
mer, de Brouwer, &Karaguzel, 2005). Our results showed that
the contribution of GJB2 mutations to ARNSHL is 7.5% in
Yazd Province, which is similar to the presented data from the
Baluhi population in southeast Iran. Naghavi et al. (Naghavi
et al., 2008) screened 100 ARNSHL families from Sistan and
Baluchistan Provinces in southeast Iran for GJB2 mutations.
They reported thatGJB2mutations were detected in 7% of the
ARNSHL families studied.
Another finding of this study was the mutation spectrum
of the Yazd Province, which was different from those of Ira-
nian population regions. Bazazzadegan et al. screened 120
NSHL families from Yazd Province in central Iran for GJB2
mutations. They reported that GJB2 mutations were found in
7.5% of the NSHL families studied. Surprisingly, c.312del14
was the most frequent GJB2 mutation (56.2% of the identi-
fied GJB2 mutations) in Yazd Province, while c.35delG was
identified in only 25% of GJB2 mutations in this province
(Bazazzadegan et al., 2012). However, the Yazdi population is
ethnically distinct from the rest of Iran. Besides, 79 unrelated
ARNSHL families from Chaharmahal and Bakhtiari Province
were reviewed, with a frequency of 6.9% forGJB2 gene muta-
tions (Chaleshtori et al., 2007). This low rate of the c.35delG
mutation has been reported in some populations of the south
and southeast of Iran like Hormozgan and Bushehr Provinces
(Chaleshtori et al., 2002).
The study performed by Koohiyan et al. (Koohiyan,
Hashemzadeh-Chaleshtorib, Salehia, & Abtahic, 2018) on 40
ARNSHL families indicated that GJB2-related HL accounts
for 31.2% in central Iran. This is about four times the fre-
quency of GJB2 mutations in Yazd Province. In addition,
Bazazzadegan et al. (2012) screened 53 NSHL families from
Lorestan Province in central Iran for GJB2 mutations. They
reported that GJB2 mutations were found in 18.8% of the
NSHL families studied. This is near the frequency of GJB2
mutations in Lorestan Province. On the basis of these results,
it can be concluded that the frequency of c.35delG decreases
gradually bothwest to east and north to south (Figure 2), draw-
ing the migration pathway of the initial founders.
In our studied populations, the most common mutation
was c.35delG, accounting for 43% of GJB2 mutations. The
c.35delG mutation is found to be the most common mutation
in many world populations as well as many countries in the
Middle East (Adhikary et al., 2015; Al-Qahtani et al., 2010;
Ghasemnejad, Khaniani, Zarei, Farbodnia, & Derakhsahan,
2017; Vozzi et al., 2014; Yoong et al., 2011). The analysis of
the geographical distribution ofmutations located in theGJB2
gene showed more allelic heterogeneity in central compared
to southern Iran (Esmaeili, Bonyadi, & Nejadkazem, 2007;
Mahdieh et al., 2004). The five most frequent mutations of
the GJB2 gene in central Iran, namely, c.35delG, c.312del14,
c.457G > A, c.358_360delGAG, and c.363delC are responsi-
ble for 56% of all pathogenic alleles in central Iran (Table 1).
110 KOOHIYAN ET AL.
TABLE 1 GJB2 mutations, their frequencies, and in silico analyses in central provinces of Iran
No. (%) Functional effect
Mutations Isfahan Lorestan
Chaharmahal
and Bakhtiari
Qom and
Markazi Yazd
Mutation
type Classification
Mutation
taster SIFT
c.23_24insA 1 (1.25) 0 0 0 0 Frameshift NT Disease
causing
Damaging
c.35delG 12 (15) 10 (9.4) 5 (3.1) 7 (8.7) 4 (1.6) Deletion/
nonsense
T Disease
causing
NA
c.35G > T 1 (1.25) 0 0 0 0 Missense NT Disease
causing
Damaging
c.95G > A 2 (2.5) 0 0 0 0 Missense NT Disease
causing
Damaging
c.100A > G 1 (1.25) 0 0 0 0 Missense NT Disease
causing
Damaging
c.130T > G 1 (1.25) 0 0 0 0 Missense NT Disease
causing
Damaging
c.163A > G 1 (1.25) 0 0 0 0 Missense NT Disease
causing
Damaging
c.167delT 0 0 0 0 1 (0.41) Frameshift T Disease
causing
NA
c.176del16 0 0 0 2 (2.5) 0 Frameshift T Disease
causing
NA
c.178T > G 1 (1.25) 0 0 0 0 Missense NT Disease
causing
Damaging
c.233delC 0 0 0 2 (2.5) 0 Frameshift T Disease
causing
NA
c.314del14 0 2 (1.8) 0 0 2 (0.83) Frameshift T Disease
causing
NA
c.312del14 0 0 0 0 9 (3.7) Frameshift T Disease
causing
NA
c.358_360delGAG 2 (2.5) 0 0 0 2 (0.83) In frame
deletion
NT Disease
causing
Damaging
c.363delc 0 0 4 (2.5) 0 0 Frameshift T Disease
causing
NA
c.510insCGAA 0 1 (0.94) 0 0 0 Frameshift T Disease
causing
NA
c.512insAACG 0 2 (1.8) 0 0 0 Frameshift T Disease
causing
NA
c.23+1G > A 0 1 (0.94) 0 0 0 Missense T Disease
causing
Damaging
c.79G > A 1 (1.25) 0 1 (1.25) 0 0 Missense NT Polymorphism Tolerated
c.314A > G 1 (1.25) 0 0 0 0 Missense NT Polymorphism Tolerated
c.457G > A 1 (1.25) 4 (3.7) 1 (1.25) 2 (2.5) 0 Missense NT Polymorphism Tolerated
Normal 55 86 147 67 222
Total 80 106 158 80 240
Note. T, truncated protein; NT, nontruncated protein; NA: not available.
The c.35delG mutation, which is the most common (up
to 85%) among northern regions (Chaleshtori et al., 2007),
makes up for 43% of GJB2 mutations in the central popula-
tion. The c.312del14, c.457G>A, and c.358_360delGAG are
the second, third, and fourth most common mutations, with
a total of 10.2%, 9.1%, and 4.5% of all pathogenic alleles.
The c.312del14 mutation, a frameshift variant, leads to the
formation of a premature stop codon at amino acid position
109, which results in a truncated protein with probably no
functional properties. In silico analyses are consistent with
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the pathogenicity of the mutation (Table 1). The c.312del14
mutation is the raremutation in Iranian populations (Hashemi,
Ashraf, Saboori, Azarpira, & Darai, 2012), but this muta-
tion shows a high frequency in Yazd Province (accounts for
56% of the mutant alleles), because of founder effects. Yazdi
populations are isolated with cultural, lingual, religious, and
geographical barriers from other parts of Iran. V153I, a mis-
sense mutation is the result of c.457G > A transition, chang-
ing a TGG codon for a valine residue to a TGA codon for
isoleucine, which probably leads to a nonfunctional protein
(Rabionet, Gasparini, & Estivill, 2000). The pathogenic effect
of this amino acid substitution is controversial and remains to
be confirmed.
More recently, researchers have shown that mutations of
GJB2 can function in a digenic manner with the GJB3 or
GJB6 genes (Rodriguez-Paris & Schrijver, 2009). Hence,
mutation analysis of this gene should be considered in
GJB2 heterozygotes (Kooshavar et al., 2013; Lin et al.,
2001). Because of the high frequency of GJB2 mutations
in many populations, GJB2 analysis should be depicted for
HL, although the frequency of GJB2-related HL in Iran
is lower than that of European countries (Gasparini et al.,
2000; Lucotte, 2007). Hashemzadeh-Chaleshtori et al. (2008)
showed that more than 40% of patients were heterozygous car-
riers in south and southeast Iran (Chaleshtori et al., 2002). Fur-
ther investigation is needed to detect the genetic cause of HL
in patients with monoallelic GJB2 mutations (Shahin et al.,
2002; Walid, Bassel, Ali, & Moassass, 2017).
5 CONCLUSION
The critical and specific position of Iran and the existence of
various ethnic groups with different cultures suggest the high
heterogeneity throughout Iran, but specific intraethnic tradi-
tions such as intragroup marriages may give rise to a high
homogeneity in some loci and mutations within groups.GJB2
mutations are responsible for ∼16% of deaf families in cen-
tral Iran, which is less than that in northwest Iran (22%–27%),
showing a migration pathway from west to east through the
silk route. Regarding the GJB2 mutations, c.35delG is the
most common mutation that is tested first. In studied popu-
lations, specific mutations are common, which are detected in
each group; for example, the frequency of c.312del14 shows a
high rate in Yazd Province, accounting for 56% of the mutant
alleles. This study highlights the importance of establishing
incidence based on the local population of specific and com-
mon GJB2 mutations in designing screening strategies.
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